Esther12
Senior Member (Voting Rights)
Is a COSMID required to comment? I'd imagine so, wanting comments from professionals and not random people?
Looks like just name and e-mail is needed. I'd be surprised if she wanted to exclude patients!
Is a COSMID required to comment? I'd imagine so, wanting comments from professionals and not random people?
It asks for an 'ORCID code' too. I could not see any comments so I wondered if you need be 'signed in' some how to comment.Looks like just name and e-mail is needed. I'd be surprised if she wanted to exclude patients!
It asks for an 'ORCID code' too. I could not see any comments so I wondered if you need be 'signed in' some how to comment.
Well done and thanks to everyone who did this.I am grateful to the many people who have urged me to look at the issues related to the PACE trial and the related Cochrane review in recent years: you were all right – it was worth the effort. (I’m not naming any, as there were so many over the years that I’m sure to leave someone out: this was a mountain made of molehills.)
Well done and thanks to everyone who did this.It wasn't me (though perhaps she might also have read some of my comments on PubMed Commons when she ran it).
Robert Courtney and Tom Kindlon are both people with lives severely affected by ME/CFS, who critiqued the PACE trial intensively. They posted detailed analyses of the Cochrane review and its verdict on the PACE trial and other evidence in Cochrane’s commenting system. Their comments from 2015 to 2016 raised important issues, but the review’s authors rather brushed off their concerns.
Sometimes, a dispute with a consumer movement comes along that has profound implications for far more than the people in it. I think the dramatic clash between the ME/CFS patient community and a power base in the evidence community is one of those. It points to weaknesses in research methodology and practice that don’t get enough critical attention. It raises uncomfortable questions about the relationship between researchers and policy communities. And it pushes the envelope on open data in clinical trials, too.
White and colleagues’ proposal became the PACE trial in 2005, after the MRC awarded it the biggest grant ever for an ME/CFS trial.
Well done and thanks to everyone who did this.It wasn't me (though perhaps she might also have read some of my comments on PubMed Commons when she ran it).
That’s a lot to achieve from consumer pushback on research, so kudos to Courtney and Kindlon for their effort.
I was a health consumer advocate (aka patient advocate) from 1983 to 2003, including chairing the Consumers’ Health Forum of Australia (CHF)...
It is good, especially for someone from outside the usual ME advocacy circles. This definition of pacing bothered me though. I blame @Action for M.E. for it a lot more than Hilda Bastian.
Pacing isn't a treatment that assures your condition stabilises or, much less, that recovery is achieved.
Pacing doesn't involve 'very gradually increasing activities'. That sounds a lot more like 'graded exercise therapy' or the now more fashionable 'graded activity therapy'.
Subsequent posts related to pacing having been moved to a thread in Lifestyle Management:
https://www.s4me.info/threads/pacing-definitions-and-sources-of-information.8098/
It's a good article.
One issue for me is the use of the term "consumer". I know this is a Cochrane thing (well, that's me told anyway), but part of the issues stem from terminology that divides people into groups or "camps", when in reality these groups are fairly fluid.
It is also the fact that a self-appointed authority group gets to decide what other parties are called, without much in the way of negotiation on the issue.
Do you feel like consumers (even healthcare consumers)? Or is the lack of access to adequate healthcare in this field a disqualifying factor here?
I'm not a "consumer". I wasn't initially an "activist" either. I can't even be a proper "advocate" - you're all perfectly able to speak for yourselves!
I'm no longer an "academic" or a "researcher" - although I'd like to get back to that - if any institution would ever have me back.
Guess I'll have to stick with the term "unemployed troublemaker"!
https://www.me-pedia.org/wiki/Action_for_ME#Involvement_in_PACE_trial_controversyI’m not familiar with this action for ME and how they actually worked and opposed PACE in the initial phase, if at all.
Ok, thanks. And wow. Know PACE as presented and trial 2011 to date, but wasn’t aware of afME close relationship to both governments, PACE investigators and insurers. But should have known, -cause how could you set up that kind of trial without support of people you “control”?
It's a good article.
One issue for me is the use of the term "consumer". I know this is a Cochrane thing (well, that's me told anyway), but part of the issues stem from terminology that divides people into groups or "camps", when in reality these groups are fairly fluid.
It is also the fact that a self-appointed authority group gets to decide what other parties are called, without much in the way of negotiation on the issue.
Do you feel like consumers (even healthcare consumers)? Or is the lack of access to adequate healthcare in this field a disqualifying factor here?
I'm not a "consumer". I wasn't initially an "activist" either. I can't even be a proper "advocate" - you're all perfectly able to speak for yourselves!
I'm no longer an "academic" or a "researcher" - although I'd like to get back to that - if any institution would ever have me back.
Guess I'll have to stick with the term "unemployed troublemaker"!